Filing Details
- Accession Number:
- 0001110803-10-000208
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-09-29 13:00:00
- Reporting Period:
- 2010-09-28
- Filing Date:
- 2010-09-29
- Accepted Time:
- 2010-09-29 20:19:34
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1110803 | Illumina Inc | ILMN | Laboratory Analytical Instruments (3826) | 330804655 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1215631 | Tristan Orpin | 9885 Towne Centre Drive San Diego CA 92121-1975 | Sr Vp & Chief Commercial Offic | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2010-09-28 | 8,000 | $20.04 | 40,246 | No | 4 | M | Direct | |
Common Stock | Disposition | 2010-09-28 | 8,000 | $49.38 | 32,246 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2010-09-28 | 16,000 | $20.04 | 48,246 | No | 4 | M | Direct | |
Common Stock | Disposition | 2010-09-28 | 16,000 | $50.00 | 32,246 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2010-09-28 | 24,000 | $0.00 | 24,000 | $20.04 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
162,001 | 2007-02-25 | 2017-01-25 | No | 4 | M | Direct |
Footnotes
- The sale was made pursuant to a 10b5-1 plan.